Correlation Between Serum Cardiac Markers and Myocardial Infarct Size Quantified by Myocardial Perfusion Imaging in Patients With Hypertrophic Cardiomyopathy After Alcohol Septal Ablation

American Journal of Cardiology

Volumn 105, Issue 2, 2010, Pages 261-266

  Hage, Fadi G ^a,b   Aqel, Raed ^a,b   Aljaroudi, Wael ^a   Heo, Jaekyeong ^a   Pothineni, Koteswara ^a   Hansalia, Sachin ^a   Lawson, David ^a   Dubovsky, Eva ^a   Iskandrian, Ami E ^a  

^a University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN I; WARFARIN;

ADULT; ALCOHOL SEPTAL ABLATION; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR PROCEDURES; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE PERFUSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ABLATION TECHNIQUES; ADULT; AGED; BIOLOGICAL MARKERS; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; CREATINE KINASE, MB FORM; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SOLVENTS; TROPONIN I;

EID: 73149098516     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.680     Document Type: Article

References (25)

1. Aqel R.A., Hage F.G., Zohgbi G.J., Tabereaux P.B., Lawson D., Heo J., Perry G., Epstein A.E., Dell'Italia L.J., and Iskandrian A.E. Serial evaluations of myocardial infarct size after alcohol septal ablation in hypertrophic cardiomyopathy and effects of the changes on clinical status and left ventricular outflow pressure gradients. Am J Cardiol 101 (2008) 1328-1333
2. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 48 (2006) 1-11
3. Roberts R., Henry P.D., and Sobel B.E. An improved basis for enzymatic estimation of infarct size. Circulation 52 (1975) 743-754
4. Gibbons R.J., Valeti U.S., Araoz P.A., and Jaffe A.S. The quantification of infarct size. J Am Coll Cardiol 44 (2004) 1533-1542
5. Saenger A.K., and Jaffe A.S. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Med Clin North Am 91 (2007) 657-681
6. Giannitsis E., Steen H., Kurz K., Ivandic B., Simon A.C., Futterer S., Schild C., Isfort P., Jaffe A.S., and Katus H.A. Cardiac magnetic resonance imaging study for quantification of infarct size comparing directly serial versus single time-point measurements of cardiac troponin T. J Am Coll Cardiol 51 (2008) 307-314
7. Steen H., Giannitsis E., Futterer S., Merten C., Juenger C., and Katus H.A. Cardiac troponin T at 96 hours after acute myocardial infarction correlates with infarct size and cardiac function. J Am Coll Cardiol 48 (2006) 2192-2194
8. Hedstrom E., Astrom-Olsson K., Ohlin H., Frogner F., Carlsson M., Billgren T., Jovinge S., Cain P., Wagner G.S., and Arheden H. Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion. Scand Cardiovasc J 41 (2007) 44-50
9. Licka M., Zimmermann R., Zehelein J., Dengler T.J., Katus H.A., and Kubler W. Troponin T concentrations 72 hours after myocardial infarction as a serological estimate of infarct size. Heart 87 (2002) 520-524
10. Younger J.F., Plein S., Barth J., Ridgway J.P., Ball S.G., and Greenwood J.P. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart 93 (2007) 1547-1551
11. Costa T.N., Cassaro Strunz C.M., Nicolau J.C., and Gutierrez P.S. Comparison of MB fraction of creatine kinase mass and troponin I serum levels with necropsy findings in acute myocardial infarction. Am J Cardiol 101 (2008) 311-314
12. Tzivoni D., Koukoui D., Guetta V., Novack L., and Cowing G. Comparison of troponin T to creatine kinase and to radionuclide cardiac imaging infarct size in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Am J Cardiol 101 (2008) 753-757
13. Daniels L.B., and Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 50 (2007) 2357-2368
14. Ceriani L., and Giovanella L. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography. Clin Chem Lab Med 45 (2007) 226-231
15. Nakagawa K., Umetani K., Fujioka D., Sano K., Nakamura T., Kodama Y., Kitta Y., Ichigi Y., Kawabata K., Obata J.E., Takano H., Inobe Y., and Kugiyama K. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J 68 (2004) 923-927
16. Ndrepepa G., Braun S., Mehilli J., von Beckerath N., Nekolla S., Vogt W., Schwaiger M., Schomig A., and Kastrati A. N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. Am J Cardiol 97 (2006) 1151-1156
17. Hasegawa K., Fujiwara H., Doyama K., Miyamae M., Fujiwara T., Suga S., Mukoyama M., Nakao K., Imura H., and Sasayama S. Ventricular expression of brain natriuretic peptide in hypertrophic cardiomyopathy. Circulation 88 (1993) 372-380
18. Maron B.J., Tholakanahalli V.N., Zenovich A.G., Casey S.A., Duprez D., Aeppli D.M., and Cohn J.N. Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy. Circulation 109 (2004) 984-989
19. Nishigaki K., Tomita M., Kagawa K., Noda T., Minatoguchi S., Oda H., Watanabe S., Morita N., Nakao K., and Fujiwara H. Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 28 (1996) 1234-1242
20. Mottram P.M., Leano R., and Marwick T.H. Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function. Am J Cardiol 92 (2003) 1434-1438
21. Binder J., Ommen S.R., Chen H.H., Ackerman M.J., Tajik A.J., and Jaffe A.S. Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol 100 (2007) 712-714
22. Hage F.G., Karakus G., Luke Jr. W.D., Suwanjutah T., Nanda N.C., and Aqel R.A. Effect of alcohol-induced septal ablation on left atrial volume and ejection fraction assessed by real-time three-dimensional transthoracic echocardiography in patients with hypertrophic cardiomyopathy. Echocardiography 25 (2008) 784-789
23. Grewal J., McKelvie R.S., Persson H., Tait P., Carlsson J., Swedberg K., Ostergren J., and Lonn E. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol 102 (2008) 733-737
24. Ibrahim T., Nekolla S.G., Hornke M., Bulow H.P., Dirschinger J., Schomig A., and Schwaiger M. Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol 45 (2005) 544-552
25. Lewis G.D., Wei R., Liu E., Yang E., Shi X., Martinovic M., Farrell L., Asnani A., Cyrille M., Ramanathan A., Shaham O., Berriz G., Lowry P.A., Palacios I.F., Tasan M., Roth F.P., Min J., Baumgartner C., Keshishian H., Addona T., Mootha V.K., Rosenzweig A., Carr S.A., Fifer M.A., Sabatine M.S., and Gerszten R.E. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118 (2008) 3503-3512